Related Experiment Videos
[Cryptosporidium enteritis]
B Wilmsmeyer1, R Dopfer, J E Hoppe
1Universitäts-Kinderklinik Tübingen.
Abstract:
Cryptosporidium has been found to be a common cause of gastroenteritis during the last years. The natural course of the disease in immunocompromised patients is often met by serious complications. A general therapy recommendation has not been reported so far. We report of a two-year-old boy, who was immunocompromised by a multidrug cytostatic chemotherapy. The patient suffered from a long lasting most severe gastroenteritis, caused by cryptosporidium. There was a good clinical response to spiramycin, a treatment suggested in the literature.
Insights
Cryptosporidium causes severe gastroenteritis in immunocompromised patients. Spiramycin showed a good clinical response in a child undergoing chemotherapy, suggesting its potential as a treatment.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pediatric Gastroenterology
Background:
- Cryptosporidium is a frequent cause of gastroenteritis.
- Immunocompromised individuals face severe complications from Cryptosporidium infections.
- There is a lack of established therapeutic guidelines for Cryptosporidium gastroenteritis.
Observation:
- A two-year-old boy, immunocompromised due to multidrug cytostatic chemotherapy, presented with severe, prolonged gastroenteritis.
- The patient's condition was diagnosed as Cryptosporidium infection.
Findings:
- The patient received spiramycin for the Cryptosporidium infection.
- A positive clinical response to spiramycin was observed.
Implications:
- Spiramycin may be an effective treatment option for severe Cryptosporidium gastroenteritis in immunocompromised pediatric patients.
- Further research is warranted to establish definitive treatment protocols for this patient population.